-1.70%
18.68%
13.20%
-28.96%
-30.76%
-85.04%
-48.94%
AI Spotlight on RVP
Company Description
Retractable Technologies, Inc.designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally.It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.
The company distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network.Retractable Technologies, Inc.was incorporated in 1994 and is headquartered in Little Elm, Texas.
Market Data
| Last Price | 0.82 |
| Change Percentage | -1.70% |
| Open | 0.85 |
| Previous Close | 0.83 |
| Market Cap ( Millions) | 24 |
| Volume | 14777 |
| Year High | 1.34 |
| Year Low | 0.56 |
| M A 50 | 0.68 |
| M A 200 | 0.9 |
Financial Ratios
| FCF Yield | -40.29% |
| Dividend Yield | 0.00% |
| ROE | -17.11% |
| Debt / Equity | 1.57% |
| Net Debt / EBIDTA | -1458.64% |
| Price To Book | 0.29 |
| Price Earnings Ratio | -1.55 |
| Price To FCF | -2.48 |
| Price To sales | 0.64 |
| EV / EBITDA | 122.35 |
News
- Jan -14 - Retractable Technologies, Inc. Withdraws Complaint in United States Court of International Trade
- Nov -14 - Retractable Technologies, Inc. Results for the Periods Ended September 30, 2024
- Sep -30 - Retractable Technologies, Inc. Files Complaint in United States Court of International Trade
- Sep -20 - Tariffs Finalized on Chinese Imports
- May -15 - Retractable Technologies, Inc. Results for the Period Ended March 31, 2024
- Mar -29 - Retractable Technologies, Inc. Reports Results for 2023
- Mar -29 - Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
- Jan -22 - 3 Stocks with Major Insider Buying This Month
- Dec -01 - Retractable Technologies, Inc. Not Impacted by FDA Safety Communication
- Nov -14 - Retractable Technologies, Inc. Results for the Periods Ended September 30, 2023
- Aug -14 - Retractable Technologies, Inc. Results for the Period Ended June 30, 2023
- Jan -26 - Retractable Technologies Offers At Least 100% Potential Upside
- Dec -21 - Top 10 Quality, Value & Momentum Quant Stocks for December Revealed Here
- Nov -24 - 7 Penny Stocks Primed for Huge Moves in December
- Jun -07 - Retractable Technologies: A Very Promising Small-Cap Healthcare Stock
- Jun -07 - Safety Medical Devices-Focused Retractable Tech Cuts Its Workforce
- May -03 - Penny Stocks To Buy Now? Insiders Threw Big Money At These 4 Stocks
- Oct -02 - Here's What Warren Buffett Looks For With Healthcare Stocks
- Sep -30 - Retractable Technologies, Inc. Declares Dividends to Series II Class B Convertible Preferred Stock Shareholders
- Sep -29 - Retractable Technologies: Unfairly Punished, ~27% Upside Potential Under-Reflected
Business Breakdown
Expected Mid-Term Growth
Segment n°1 -> Syringes
Expected Growth : 8.5 %
What the company do ?
Syringes from Retractable Technologies, Inc. are safety-engineered medical devices designed to reduce the risk of accidental needlestick injuries and prevent reuse.
Why we expect these perspectives ?
Growing demand for safety-engineered medical devices, increasing awareness about needlestick injuries, and government regulations promoting the use of safety syringes drive the market growth.
Segment n°2 -> EasyPoint Needles
Expected Growth : 8.1 %
What the company do ?
EasyPoint Needles from Retractable Technologies, Inc. are safety-engineered needles with a retractable needle shield to reduce accidental needlestick injuries.
Why we expect these perspectives ?
Growing demand for safety-engineered needles, increasing awareness about needlestick injuries, and government regulations promoting the use of safety needles drive the growth of the EasyPoint Needles market.
Segment n°3 -> Blood Collection
Expected Growth : 8.1 %
What the company do ?
Blood Collection from Retractable Technologies, Inc. is a safety-engineered device for collecting blood samples, reducing needlestick injuries and bloodborne pathogen transmission.
Why we expect these perspectives ?
Growing demand for safety-engineered devices, increasing awareness of needlestick injuries and bloodborne pathogen transmission, and advancements in medical technology are expected to drive the growth of the blood collection market.
Segment n°4 -> Other
Expected Growth : 5.5 %
What the company do ?
The 'Other' segment from Retractable Technologies, Inc. includes revenue from licensing agreements and sales of non-medical products.
Why we expect these perspectives ?
The 'Other' segment's growth is driven by increasing demand for licensing agreements and non-medical products, fueled by advancements in technology and growing partnerships.
Retractable Technologies, Inc. Products
| Product Range | What is it ? |
|---|---|
| VanishPoint | A line of safety syringes designed to reduce the risk of needlestick injuries and prevent reuse. |
| PatientSafe | A syringe designed for patient safety, featuring a retractable needle to prevent needlestick injuries. |
| VanishPoint Blood Collection | A blood collection device with a retractable needle, designed to reduce the risk of needlestick injuries. |
| Retractable IV Catheter | A safety IV catheter with a retractable needle, designed to reduce the risk of needlestick injuries. |
Retractable Technologies, Inc.'s Porter Forces
Threat Of Substitutes
Retractable Technologies, Inc. has a moderate threat of substitutes due to the presence of alternative products in the market, but the company's patented technology and high-quality products help to mitigate this threat.
Bargaining Power Of Customers
Retractable Technologies, Inc. has a low bargaining power of customers due to the company's strong brand reputation and the lack of concentration in the buyer's market.
Bargaining Power Of Suppliers
Retractable Technologies, Inc. has a moderate bargaining power of suppliers due to the presence of multiple suppliers in the market, but the company's long-term contracts and strategic partnerships help to mitigate this threat.
Threat Of New Entrants
Retractable Technologies, Inc. has a high threat of new entrants due to the low barriers to entry in the market and the attractiveness of the industry, but the company's patented technology and strong brand reputation help to deter new entrants.
Intensity Of Rivalry
Retractable Technologies, Inc. operates in a highly competitive market with several established players, leading to a high intensity of rivalry among competitors.
Capital Structure
| Value | |
|---|---|
| Debt Weight | 1.53% |
| Debt Cost | 12.54% |
| Equity Weight | 98.47% |
| Equity Cost | 14.45% |
| WACC | 14.42% |
| Leverage | 1.55% |
Retractable Technologies, Inc. : Quality Control
Retractable Technologies, Inc. passed 4 out of 9 key points:
Historical Valuation
Price/Earnings Ratio
Margin Valuation
Peers Valuation
Competitors
| Company | Rational |
|---|---|
| EKSO | Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, … |
| SMTI | Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen … |
| ATRC | AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. … |
| STXS | Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the … |
| BLFS | BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. … |
Peers Metrics
DCF BETA
Expected Cash-Flows
Scoring Insights
Peers Group Analysis
🥇
Retractable Technologies
A-Score
1-Year Total Return ->
🥈
BioLife Solutions
A-Score
1-Year Total Return ->
🥉
Stereotaxis
A-Score
1-Year Total Return ->
4
Sanara MedTech
A-Score
1-Year Total Return ->
5
AtriCure
A-Score
1-Year Total Return ->
6
